Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jan 7, 2019; 25(1): 107-117
Published online Jan 7, 2019. doi: 10.3748/wjg.v25.i1.107
Table 2 The characteristics of patients at enrollment
Acute pancreatitis (n = 78)Other disease (n = 16)
Age, median (IQR), yr57 (28)61 (26)
Sex, n: male/female50/269/7
Etiology of acute pancreatitis, n (%)
Alcohol26 (33.3)
Gallstones13 (16.7)
Idiopathic12 (15.4)
Post-ERCP5 (6.4)
Others22 (28.2)
Prognostic factor score by JMHLW (2008) criteria (n = 78)
Mean (SD)0.9 (1.2)
Severe acute pancreatitis (≥ 3), n (%)9 (11.5)
Score of CT Grade by JMHLW (2008) criteria (n = 70)
Mean (SD)1.0 (1.2)
Severe acute pancreatitis (Score ≥ 2), n (%)28 (40)

  • Citation: Yasuda H, Kataoka K, Takeyama Y, Takeda K, Ito T, Mayumi T, Isaji S, Mine T, Kitagawa M, Kiriyama S, Sakagami J, Masamune A, Inui K, Hirano K, Akashi R, Yokoe M, Sogame Y, Okazaki K, Morioka C, Kihara Y, Kawa S, Tanaka M, Andoh A, Kimura W, Nishimori I, Furuse J, Yokota I, Shimosegawa T. Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan. World J Gastroenterol 2019; 25(1): 107-117
  • URL: https://www.wjgnet.com/1007-9327/full/v25/i1/107.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v25.i1.107